https://researchtopractice.com/activity/ 2026-06-09T13:26:43+00:00 https://researchtopractice.com/activity/current-and-future-role-of-trop2-directed-antibody-drug-conjugates-in-non-small-cell-lung-cancer-issue-4/ 2026-04-27T19:51:31+00:00 https://researchtopractice.com/activity/the-role-of-oral-selective-estrogen-receptor-degraders-in-the-management-of-er-positive-metastatic-breast-cancer-2/ 2026-04-30T13:06:38+00:00 https://researchtopractice.com/activity/what-is-molecular-residual-disease-analysis-and-why-is-it-clinically-relevant-in-colorectal-cancer/ 2026-04-30T16:00:53+00:00 https://researchtopractice.com/activity/current-and-future-management-of-extrapulmonary-neuroendocrine-carcinoma/ 2026-04-30T19:49:09+00:00 https://researchtopractice.com/activity/chimeric-antigen-receptor-car-t-cell-therapy-for-multiple-myeloma/ 2026-04-30T20:54:14+00:00 https://researchtopractice.com/activity/clinical-experts-address-common-questions-posed-by-patients-with-relapsed-refractory-multiple-myeloma/ 2026-05-01T14:28:20+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-menin-inhibitors-in-acute-myeloid-leukemia/ 2026-05-04T21:38:10+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-menin-inhibitors-in-acute-myeloid-leukemia-2/ 2026-05-04T21:38:26+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-menin-inhibitors-in-acute-myeloid-leukemia-3/ 2026-05-04T21:38:37+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-egfr-mutant-non-small-cell-lung-cancer-4/ 2026-05-04T21:49:18+00:00 https://researchtopractice.com/activity/current-and-future-role-of-cd19-x-cd3-bispecific-t-cell-engaging-antibodies-in-the-treatment-of-acute-lymphoblastic-leukemia-2/ 2026-05-04T21:54:01+00:00 https://researchtopractice.com/activity/key-presentations-from-the-2025-american-society-of-hematology-ash-annual-meeting-chronic-lymphocytic-leukemia/ 2026-05-04T21:56:00+00:00 https://researchtopractice.com/activity/key-presentations-from-the-2025-american-society-of-hematology-ash-annual-meeting-chronic-lymphocytic-leukemia-2/ 2026-05-04T21:56:18+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-ovarian-cancer/ 2026-05-04T21:56:48+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-ovarian-cancer-2/ 2026-05-04T21:56:59+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-ovarian-cancer-3/ 2026-05-04T21:57:10+00:00 https://researchtopractice.com/activity/oncology-today-with-dr-neil-love-optimal-management-of-squamous-cell-carcinoma-of-the-anal-canal-2/ 2026-05-04T21:59:25+00:00 https://researchtopractice.com/activity/novel-investigational-antibody-drug-conjugates-for-ovarian-cancer/ 2026-05-04T22:00:01+00:00 https://researchtopractice.com/activity/esmo-congress-2025-review-gynecologic-cancers/ 2026-05-04T22:04:55+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-antibody-drug-conjugates-for-breast-cancer/ 2026-05-04T22:10:38+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-antibody-drug-conjugates-for-breast-cancer-2/ 2026-05-04T22:10:53+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-antibody-drug-conjugates-for-breast-cancer-3/ 2026-05-04T22:11:08+00:00 https://researchtopractice.com/activity/2025-esmo-annual-meeting-breast-cancer-microlearning-activity-3/ 2026-05-04T22:43:03+00:00 https://researchtopractice.com/activity/esmo-congress-2025-urothelial-bladder-cancer-and-prostate-cancer/ 2026-05-04T22:45:05+00:00 https://researchtopractice.com/activity/current-and-future-management-of-idh-mutant-low-grade-glioma/ 2026-05-05T01:15:43+00:00 https://researchtopractice.com/activity/current-and-future-management-of-idh-mutant-low-grade-glioma-2/ 2026-05-05T01:18:40+00:00 https://researchtopractice.com/activity/an-interview-with-shannon-n-westin-md-mph-fasco-facog-current-management-of-ovarian-and-endometrial-cancer/ 2026-05-05T01:38:15+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-nontargeted-approaches-for-lung-cancer/ 2026-05-05T01:42:05+00:00 https://researchtopractice.com/activity/investigator-perspectives-on-available-research-findings-and-challenging-questions-in-the-management-of-soft-tissue-sarcoma-and-other-connective-tissue-neoplasms/ 2026-05-05T01:45:09+00:00 https://researchtopractice.com/activity/investigator-perspectives-on-available-research-findings-and-challenging-questions-in-the-management-of-renal-cell-carcinoma/ 2026-05-05T01:48:12+00:00 https://researchtopractice.com/activity/optimizing-the-management-of-endocrine-resistant-hr-positive-metastatic-breast-cancer/ 2026-05-05T01:50:42+00:00 https://researchtopractice.com/activity/optimizing-the-management-of-endocrine-resistant-hr-positive-metastatic-breast-cancer-2/ 2026-05-05T01:52:09+00:00 https://researchtopractice.com/activity/defining-the-future-role-of-trop2-directed-antibody-drug-conjugates-in-non-small-cell-lung-cancer-issue-1/ 2026-05-05T02:04:23+00:00 https://researchtopractice.com/activity/optimal-management-of-brain-metastases-in-patients-with-her2-positive-breast-cancer/ 2026-05-05T02:05:26+00:00 https://researchtopractice.com/activity/optimal-management-of-brain-metastases-in-patients-with-her2-positive-breast-cancer-2/ 2026-05-05T02:06:14+00:00 https://researchtopractice.com/activity/defining-the-current-and-future-role-of-trop2-directed-antibody-drug-conjugates-in-breast-cancer-issue-2/ 2026-05-05T02:08:00+00:00 https://researchtopractice.com/activity/defining-the-current-and-future-role-of-trop2-directed-antibody-drug-conjugates-in-breast-cancer-issue-1/ 2026-05-05T02:08:49+00:00 https://researchtopractice.com/activity/optimizing-the-management-of-metastatic-brca-negative-triple-negative-breast-cancer-3/ 2026-05-05T02:10:10+00:00 https://researchtopractice.com/activity/optimizing-the-management-of-metastatic-brca-negative-triple-negative-breast-cancer-4/ 2026-05-05T02:10:48+00:00 https://researchtopractice.com/activity/defining-the-future-role-of-trop2-directed-antibody-drug-conjugates-in-non-small-cell-lung-cancer-issue-2/ 2026-05-05T02:18:18+00:00 https://researchtopractice.com/activity/current-and-future-management-of-extrapulmonary-neuroendocrine-carcinoma-2/ 2026-05-05T02:21:30+00:00 https://researchtopractice.com/activity/defining-the-current-and-future-role-of-trop2-directed-antibody-drug-conjugates-in-breast-cancer-issue-3/ 2026-05-05T02:22:06+00:00 https://researchtopractice.com/activity/the-role-of-oral-selective-estrogen-receptor-degraders-in-the-management-of-er-positive-metastatic-breast-cancer/ 2026-05-05T02:23:37+00:00 https://researchtopractice.com/activity/current-and-future-role-of-molecular-residual-disease-analysis-and-its-relevance-in-colorectal-cancer-2/ 2026-05-05T13:40:14+00:00 https://researchtopractice.com/activity/current-and-future-role-of-molecular-residual-disease-analysis-and-its-relevance-in-colorectal-cancer/ 2026-05-05T13:43:57+00:00 https://researchtopractice.com/activity/optimizing-the-integration-of-adcs-into-the-treatment-of-hr-positive-and-triple-negative-metastatic-breast-cancer-2/ 2026-05-05T14:02:46+00:00 https://researchtopractice.com/activity/optimizing-the-integration-of-adcs-into-the-treatment-of-hr-positive-and-triple-negative-metastatic-breast-cancer/ 2026-05-05T14:05:59+00:00 https://researchtopractice.com/activity/key-presentations-from-the-2025-asco-annual-meeting-and-the-eha-2025-congress-acute-myeloid-leukemia-edition-2/ 2026-05-05T14:12:06+00:00 https://researchtopractice.com/activity/key-presentations-from-the-2025-asco-annual-meeting-and-the-eha-2025-congress-acute-myeloid-leukemia-edition/ 2026-05-05T14:15:05+00:00 https://researchtopractice.com/activity/current-and-future-role-of-trop2-directed-antibody-drug-conjugates-in-non-small-cell-lung-cancer-issue-3/ 2026-05-05T14:18:02+00:00 https://researchtopractice.com/activity/defining-the-current-and-future-role-of-trop2-directed-antibody-drug-conjugates-in-breast-cancer-issue-4/ 2026-05-05T19:39:24+00:00 https://researchtopractice.com/activity/current-and-future-management-of-her2-altered-non-small-cell-lung-cancer-2/ 2026-05-05T20:03:32+00:00 https://researchtopractice.com/activity/current-and-future-management-of-her2-altered-non-small-cell-lung-cancer/ 2026-05-05T20:16:03+00:00 https://researchtopractice.com/activity/novel-investigational-antibody-drug-conjugates-for-ovarian-cancer-2/ 2026-05-05T20:28:41+00:00 https://researchtopractice.com/activity/an-interview-with-charise-gleason-msn-np-c-aocnp-optimizing-the-care-of-patients-with-newly-diagnosed-multiple-myeloma/ 2026-05-05T21:34:22+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-oral-serds-for-breast-cancer-3/ 2026-05-06T17:51:03+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-oral-serds-for-breast-cancer-2/ 2026-05-06T17:53:44+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-oral-serds-for-breast-cancer/ 2026-05-06T17:54:12+00:00 https://researchtopractice.com/activity/an-interview-with-xavier-leleu-md-phd-optimizing-the-care-of-patients-with-newly-diagnosed-multiple-myeloma/ 2026-05-06T20:23:46+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-prostate-cancer-3/ 2026-05-06T20:27:47+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-prostate-cancer-4/ 2026-05-06T20:30:26+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-prostate-cancer-5/ 2026-05-06T20:30:51+00:00 https://researchtopractice.com/activity/discussing-common-questions-posed-by-patients-with-relapsed-refractory-multiple-myeloma/ 2026-05-07T13:31:22+00:00 https://researchtopractice.com/activity/esmo-congress-2025-review-prostate-cancer/ 2026-05-07T13:41:26+00:00 https://researchtopractice.com/activity/esmo-congress-2025-review-prostate-cancer-2/ 2026-05-07T13:43:16+00:00 https://researchtopractice.com/activity/investigators-provide-perspectives-on-actual-cases-of-metastatic-bladder-cancer/ 2026-05-07T13:54:47+00:00 https://researchtopractice.com/activity/investigators-provide-perspectives-on-actual-cases-of-metastatic-bladder-cancer-2/ 2026-05-07T14:01:22+00:00 https://researchtopractice.com/activity/investigators-provide-perspectives-on-actual-cases-of-metastatic-bladder-cancer-3/ 2026-05-07T14:08:59+00:00 https://researchtopractice.com/activity/current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays-in-the-treatment-of-lung-cancer/ 2026-05-07T18:18:31+00:00 https://researchtopractice.com/activity/2025-esmo-annual-meeting-breast-cancer-microlearning-activity-2/ 2026-05-07T19:02:37+00:00 https://researchtopractice.com/activity/2025-esmo-annual-meeting-breast-cancer-microlearning-activity-1/ 2026-05-07T19:07:54+00:00 https://researchtopractice.com/activity/2025-esmo-annual-meeting-breast-cancer-highlights/ 2026-05-07T19:40:52+00:00 https://researchtopractice.com/activity/the-new-understanding-of-toxicities-associated-with-chimeric-antigen-receptor-car-t-cell-therapy-2/ 2026-05-07T19:44:57+00:00 https://researchtopractice.com/activity/the-new-understanding-of-toxicities-associated-with-chimeric-antigen-receptor-car-t-cell-therapy/ 2026-05-07T19:53:49+00:00 https://researchtopractice.com/activity/perspectives-on-new-datasets-in-flt3-and-idh1-2-mutant-acute-myeloid-leukemia/ 2026-05-07T21:05:16+00:00 https://researchtopractice.com/activity/perspectives-on-new-datasets-in-flt3-and-idh1-2-mutant-acute-myeloid-leukemia-2/ 2026-05-07T21:05:55+00:00 https://researchtopractice.com/activity/current-and-future-role-of-menin-inhibitors-for-patients-with-acute-myeloid-leukemia/ 2026-05-07T21:09:46+00:00 https://researchtopractice.com/activity/current-and-future-role-of-menin-inhibitors-for-patients-with-acute-myeloid-leukemia-2/ 2026-05-07T21:11:01+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-therapeutic-targets-beyond-egfr-for-non-small-cell-lung-cancer-2/ 2026-05-08T14:55:39+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-therapeutic-targets-beyond-egfr-for-non-small-cell-lung-cancer/ 2026-05-08T14:59:38+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-therapeutic-targets-beyond-egfr-for-non-small-cell-lung-cancer-3/ 2026-05-08T15:02:58+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-ovarian-cancer/ 2026-05-08T15:14:53+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-gynecologic-cancers-2/ 2026-05-08T22:40:42+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-gynecologic-cancers/ 2026-05-08T22:42:50+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-gynecologic-cancers-3/ 2026-05-08T22:43:08+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-multiple-myeloma-2/ 2026-05-10T17:31:48+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-multiple-myeloma/ 2026-05-10T17:42:00+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-multiple-myeloma-3/ 2026-05-10T17:44:55+00:00 https://researchtopractice.com/activity/bispecific-antibodies-in-the-management-of-non-hodgkin-lymphoma/ 2026-05-11T16:55:37+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-myelofibrosis-edition-2/ 2026-05-11T17:05:34+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-myelofibrosis-edition/ 2026-05-11T17:08:37+00:00 https://researchtopractice.com/activity/real-world-case-presentations-and-current-questions-and-controversies-in-the-management-of-chronic-lymphocytic-leukemia/ 2026-05-11T18:00:29+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-breast-cancer-2/ 2026-05-11T19:26:59+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-breast-cancer/ 2026-05-11T19:30:07+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-breast-cancer-3/ 2026-05-11T19:35:39+00:00 https://researchtopractice.com/activity/the-implications-of-recent-datasets-for-the-current-and-future-management-of-genitourinary-cancers/ 2026-05-11T20:18:39+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-chronic-lymphocytic-leukemia-2/ 2026-05-11T20:24:05+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-chronic-lymphocytic-leukemia/ 2026-05-11T20:27:55+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-chronic-lymphocytic-leukemia-3/ 2026-05-11T20:29:36+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-non-hodgkin-lymphoma-edition-2/ 2026-05-12T13:39:32+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-non-hodgkin-lymphoma-edition/ 2026-05-12T13:43:25+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-colorectal-cancer-2/ 2026-05-13T19:50:11+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-colorectal-cancer-3/ 2026-05-13T19:52:54+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-colorectal-cancer/ 2026-05-13T19:53:59+00:00 https://researchtopractice.com/activity/rounds-with-the-investigator-a-discussion-on-the-role-of-endocrine-based-therapy-for-hr-positive-breast-cancer/ 2026-05-13T20:09:55+00:00 https://researchtopractice.com/activity/reviewing-the-role-of-oral-serds-in-the-management-of-er-positive-metastatic-breast-cancer-issue-6/ 2026-05-13T20:16:24+00:00 https://researchtopractice.com/activity/optimizing-the-management-of-neurofibromatosis-type-1-plexiform-neurofibromas/ 2026-05-13T20:23:22+00:00 https://researchtopractice.com/activity/optimizing-the-management-of-neurofibromatosis-type-1-plexiform-neurofibromas-2/ 2026-05-13T20:26:23+00:00 https://researchtopractice.com/activity/bispecific-antibodies-in-multiple-myeloma/ 2026-05-13T20:32:09+00:00 https://researchtopractice.com/activity/optimizing-the-role-of-car-t-cell-therapy-in-the-management-of-multiple-myeloma-2/ 2026-05-14T17:40:51+00:00 https://researchtopractice.com/activity/reviewing-the-role-of-oral-serds-in-the-management-of-er-positive-metastatic-breast-cancer-issue-5/ 2026-05-14T18:11:25+00:00 https://researchtopractice.com/activity/optimizing-the-selection-of-first-line-therapy-for-patients-with-multiple-myeloma/ 2026-05-14T18:41:44+00:00 https://researchtopractice.com/activity/optimal-use-of-parp-inhibitors-for-patients-with-hormone-sensitive-and-castration-resistant-metastatic-prostate-cancer/ 2026-05-14T18:58:49+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-egfr-mutant-non-small-cell-lung-cancer-5/ 2026-05-14T19:20:49+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-egfr-mutant-non-small-cell-lung-cancer-3/ 2026-05-14T19:21:13+00:00 https://researchtopractice.com/activity/optimizing-the-role-of-car-t-cell-therapy-in-the-management-of-multiple-myeloma/ 2026-05-18T14:12:11+00:00 https://researchtopractice.com/activity/understanding-and-caring-for-patients-with-nonmelanoma-skin-cancers/ 2026-05-18T15:30:03+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia/ 2026-05-22T21:30:24+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-2/ 2026-05-22T21:41:21+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-3/ 2026-05-22T21:41:36+00:00 https://researchtopractice.com/activity/patientproject2025-cartpatients/ 2026-05-26T14:37:10+00:00 https://researchtopractice.com/activity/esmo-congress-2025-review-urothelial-bladder-cancer/ 2026-05-26T14:46:18+00:00 https://researchtopractice.com/activity/bispecific-antibodies-in-lymphoma-part-1/ 2026-05-26T14:48:35+00:00 https://researchtopractice.com/activity/bispecific-antibodies-in-lymphoma-part-2/ 2026-05-26T14:48:47+00:00 https://researchtopractice.com/activity/new-datasets-and-their-implications-for-breast-cancer-management-2/ 2026-05-26T14:53:21+00:00 https://researchtopractice.com/activity/new-datasets-and-their-implications-for-breast-cancer-management/ 2026-05-26T14:53:33+00:00 https://researchtopractice.com/activity/impact-of-biomarkers-and-existing-comorbidities/ 2026-05-26T14:56:45+00:00 https://researchtopractice.com/activity/impact-of-biomarkers-and-existing-comorbidities-2/ 2026-05-26T14:56:59+00:00 https://researchtopractice.com/activity/current-and-future-role-of-cd19-x-cd3-bispecific-t-cell-engaging-antibodies-in-the-treatment-of-acute-lymphoblastic-leukemia/ 2026-05-26T15:20:02+00:00 https://researchtopractice.com/activity/current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays-in-the-treatment-of-breast-cancer/ 2026-05-26T15:20:53+00:00 https://researchtopractice.com/activity/exploring-the-potential-role-of-protac-estrogen-receptor-degraders-in-the-management-of-hr-positive-metastatic-breast-cancer-2/ 2026-05-26T15:23:22+00:00 https://researchtopractice.com/activity/exploring-the-potential-role-of-protac-estrogen-receptor-degraders-in-the-management-of-hr-positive-metastatic-breast-cancer/ 2026-05-26T15:23:33+00:00 https://researchtopractice.com/activity/optimizing-the-selection-of-first-line-therapy-for-patients-with-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement/ 2026-05-26T15:30:05+00:00 https://researchtopractice.com/activity/optimizing-the-selection-of-first-line-therapy-for-patients-with-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-2/ 2026-05-26T15:30:30+00:00 https://researchtopractice.com/activity/the-management-of-relapsed-refractory-multiple-myeloma-from-ash-2025-bcma-targeted-therapy-and-investigational-agents/ 2026-05-26T15:36:51+00:00 https://researchtopractice.com/activity/the-implications-of-recent-datasets-for-the-current-and-future-management-of-breast-cancer-an-asco-2025-review-2/ 2026-05-26T15:39:41+00:00 https://researchtopractice.com/activity/the-implications-of-recent-datasets-for-the-current-and-future-management-of-breast-cancer-an-asco-2025-review/ 2026-05-26T15:39:58+00:00 https://researchtopractice.com/activity/the-implications-of-recent-datasets-for-the-current-and-future-management-of-non-hodgkin-lymphoma/ 2026-05-26T15:41:16+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-ovarian-cancer-2/ 2026-05-26T15:45:35+00:00 https://researchtopractice.com/activity/optimal-use-of-parp-inhibitors-for-patients-with-hormone-sensitive-and-castration-resistant-metastatic-prostate-cancer-2/ 2026-05-26T15:49:11+00:00 https://researchtopractice.com/activity/investigators-discuss-available-research-guiding-the-care-of-patients-with-non-hodgkin-lymphoma/ 2026-05-26T16:05:20+00:00 https://researchtopractice.com/activity/investigators-discuss-available-research-guiding-the-care-of-patients-with-ovarian-and-endometrial-cancer/ 2026-05-26T16:06:24+00:00 https://researchtopractice.com/activity/investigators-discuss-available-research-guiding-the-selection-of-therapy-for-patients-with-chronic-lymphocytic-leukemia/ 2026-05-26T16:07:42+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-clinical-care-of-patients-with-her2-positive-gynecologic-cancers/ 2026-05-26T16:11:41+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-role-of-endocrine-based-and-other-strategies-in-the-management-of-hr-positive-breast-cancer/ 2026-05-26T16:13:47+00:00 https://researchtopractice.com/activity/investigators-discuss-available-research-guiding-the-care-of-patients-with-colorectal-cancer/ 2026-05-26T16:14:38+00:00 https://researchtopractice.com/activity/consensus-or-controversy-clinical-investigators-provide-perspectives-on-the-current-and-future-care-of-patients-with-chronic-lymphocytic-leukemia/ 2026-05-26T16:19:39+00:00 https://researchtopractice.com/activity/consensus-or-controversy-clinical-investigators-provide-perspectives-on-the-current-and-future-clinical-care-of-patients-with-metastatic-breast-cancer/ 2026-05-26T16:25:25+00:00 https://researchtopractice.com/activity/consensus-or-controversy-clinical-investigators-provide-perspectives-on-the-current-and-future-clinical-care-of-patients-with-egfr-mutation-positive-non-small-cell-lung-cancer/ 2026-05-26T16:27:40+00:00 https://researchtopractice.com/activity/consensus-or-controversy-clinical-investigators-provide-perspectives-on-the-current-and-future-clinical-care-of-patients-with-urothelial-bladder-cancer/ 2026-05-26T16:28:46+00:00 https://researchtopractice.com/activity/clinical-investigators-discuss-the-current-and-future-clinical-care-of-patients-with-her2-positive-gastrointestinal-cancers/ 2026-05-26T17:15:40+00:00 https://researchtopractice.com/activity/clinical-investigators-discuss-the-current-and-future-clinical-care-of-patients-with-prostate-cancer/ 2026-05-26T17:18:54+00:00 https://researchtopractice.com/activity/clinical-investigators-discuss-the-current-and-future-role-of-immunotherapy-and-antibody-drug-conjugates-in-lung-cancer/ 2026-05-26T17:20:06+00:00 https://researchtopractice.com/activity/practical-perspectives-on-the-current-and-future-management-of-immune-thrombocytopenia-what-happened-at-ash-2025-4/ 2026-05-26T17:28:01+00:00 https://researchtopractice.com/activity/practical-perspectives-on-the-current-and-future-management-of-immune-thrombocytopenia-what-happened-at-ash-2025-5/ 2026-05-26T17:28:37+00:00 https://researchtopractice.com/activity/practical-perspectives-on-the-current-and-future-management-of-immune-thrombocytopenia-what-happened-at-ash-2025-3/ 2026-05-26T17:29:19+00:00 https://researchtopractice.com/activity/practical-perspectives-on-the-current-and-future-management-of-immune-thrombocytopenia-what-happened-at-ash-2025-2/ 2026-05-26T17:29:50+00:00 https://researchtopractice.com/activity/clinical-investigators-explore-the-application-of-recent-datasets-in-current-oncology-care-2/ 2026-05-26T17:35:08+00:00 https://researchtopractice.com/activity/clinical-investigators-explore-the-application-of-recent-datasets-in-current-oncology-care/ 2026-05-26T17:37:21+00:00 https://researchtopractice.com/activity/clinical-investigators-explore-the-application-of-recent-datasets-in-current-oncology-care-4/ 2026-05-26T17:38:44+00:00 https://researchtopractice.com/activity/clinical-investigators-explore-the-application-of-recent-datasets-in-current-oncology-care-3/ 2026-05-26T17:41:27+00:00 https://researchtopractice.com/activity/investigators-provide-perspectives-on-the-best-practice-management-of-ovarian-cancer/ 2026-05-26T17:55:46+00:00 https://researchtopractice.com/activity/investigators-provide-perspectives-on-the-best-practice-use-of-immunotherapy-for-endometrial-cancer/ 2026-05-26T17:56:32+00:00 https://researchtopractice.com/activity/current-and-future-roles-of-immunotherapy-and-targeted-therapy-in-the-management-of-advanced-gastroesophageal-cancers-2/ 2026-05-26T18:00:52+00:00 https://researchtopractice.com/activity/current-and-future-roles-of-immunotherapy-and-targeted-therapy-in-the-management-of-advanced-gastroesophageal-cancers-3/ 2026-05-26T18:01:17+00:00 https://researchtopractice.com/activity/current-and-future-roles-of-immunotherapy-and-targeted-therapy-in-the-management-of-advanced-gastroesophageal-cancers-4/ 2026-05-26T18:01:42+00:00 https://researchtopractice.com/activity/current-and-future-roles-of-immunotherapy-and-targeted-therapy-in-the-management-of-advanced-gastroesophageal-cancers-5/ 2026-05-26T18:02:19+00:00 https://researchtopractice.com/activity/optimizing-the-use-of-immunotherapy-mrd-assessment-and-other-novel-approaches-for-patients-with-localized-colorectal-cancer/ 2026-05-26T18:04:35+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-management-of-her2-positive-gastrointestinal-cancers-4/ 2026-05-26T18:05:42+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-management-of-her2-positive-gastrointestinal-cancers/ 2026-05-26T18:06:21+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-management-of-her2-positive-gastrointestinal-cancers-2/ 2026-05-26T18:07:27+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-management-of-her2-positive-gastrointestinal-cancers-3/ 2026-05-26T18:07:58+00:00 https://researchtopractice.com/activity/optimizing-the-use-of-immunotherapy-mrd-assessment-and-other-novel-approaches-for-patients-with-localized-colorectal-cancer-4/ 2026-05-26T18:08:34+00:00 https://researchtopractice.com/activity/optimizing-the-use-of-immunotherapy-mrd-assessment-and-other-novel-approaches-for-patients-with-localized-colorectal-cancer-2/ 2026-05-26T18:10:24+00:00 https://researchtopractice.com/activity/addressing-current-knowledge-and-practice-gaps-in-the-community-optimizing-the-use-of-oral-selective-estrogen-receptor-degraders-for-metastatic-breast-cancer-part-1/ 2026-05-26T18:15:09+00:00 https://researchtopractice.com/activity/selection-of-first-line-and-maintenance-therapy-for-patients-with-extensive-stage-small-cell-lung-cancer/ 2026-05-26T18:16:08+00:00 https://researchtopractice.com/activity/inside-the-issue-celmods-for-multiple-myeloma/ 2026-05-26T18:24:00+00:00 https://researchtopractice.com/activity/inside-the-issue-celmods-for-multiple-myeloma-2/ 2026-05-26T18:24:27+00:00 https://researchtopractice.com/activity/inside-the-issue-the-emerging-role-of-cereblon-e3-ligase-modulators-in-multiple-myeloma/ 2026-05-26T18:26:00+00:00 https://researchtopractice.com/activity/patterns-of-care-examining-the-current-use-of-genetic-testing-and-related-clinical-management-for-patients-with-localized-breast-cancer/ 2026-05-26T18:43:57+00:00 https://researchtopractice.com/activity/practical-perspectives-preventing-and-managing-toxicities-associated-with-antibody-drug-conjugates-in-the-management-of-metastatic-breast-cancer/ 2026-05-26T18:59:48+00:00 https://researchtopractice.com/activity/practical-perspectives-experts-review-actual-cases-of-patients-with-advanced-gastroesophageal-cancers-part-2-of-2/ 2026-05-26T19:02:02+00:00 https://researchtopractice.com/activity/practical-perspectives-experts-review-actual-cases-of-patients-with-biliary-tract-cancers-part-2-of-2/ 2026-05-26T19:04:15+00:00 https://researchtopractice.com/activity/practical-perspectives-experts-review-actual-cases-of-patients-with-biliary-tract-cancers-part-1-of-2/ 2026-05-26T19:05:33+00:00 https://researchtopractice.com/activity/practical-perspectives-experts-review-actual-cases-of-patients-with-advanced-gastroesophageal-cancers-part-1-of-2/ 2026-05-26T19:07:42+00:00 https://researchtopractice.com/activity/practical-perspectives-experts-review-actual-cases-of-patients-with-small-cell-lung-cancer/ 2026-05-26T19:08:51+00:00 https://researchtopractice.com/activity/practical-perspectives-clinical-investigators-review-actual-cases-of-patients-with-endometrial-cancer/ 2026-05-26T19:13:04+00:00 https://researchtopractice.com/activity/questions-from-the-community-investigators-discuss-available-research-guiding-the-care-of-patients-with-relapsed-refractory-multiple-myeloma/ 2026-05-26T19:15:28+00:00 https://researchtopractice.com/activity/the-management-of-relapsed-refractory-multiple-myeloma-from-ash-2025-bcma-targeted-therapy-and-investigational-agents-2/ 2026-05-26T19:19:25+00:00 https://researchtopractice.com/activity/second-opinion-clinical-investigators-provide-perspectives-on-the-future-role-of-akt-inhibition-in-the-management-of-prostate-cancer/ 2026-05-26T19:27:19+00:00 https://researchtopractice.com/activity/second-opinion-integrating-novel-approaches-into-the-management-of-non-muscle-invasive-and-muscle-invasive-bladder-cancer/ 2026-05-26T19:29:08+00:00 https://researchtopractice.com/activity/striving-for-consensus-clinical-investigators-review-the-current-and-future-role-of-oral-serds-in-the-care-of-patients-with-er-positive-metastatic-breast-cancer/ 2026-05-26T19:37:42+00:00 https://researchtopractice.com/activity/striving-for-consensus-current-and-future-management-of-immune-thrombocytopenia/ 2026-05-26T19:40:26+00:00 https://researchtopractice.com/activity/striving-for-consensus-optimizing-the-current-and-future-management-of-relapsed-refractory-diffuse-large-b-cell-lymphoma/ 2026-05-26T19:42:13+00:00 https://researchtopractice.com/activity/striving-for-consensus-optimizing-the-multidisciplinary-management-of-nonmelanoma-skin-cancers-update-on-cutaneous-squamous-cell-and-basal-cell-carcinomas/ 2026-05-26T19:43:21+00:00 https://researchtopractice.com/activity/striving-for-consensus-optimizing-the-selection-and-sequencing-of-therapy-for-patients-with-relapsed-refractory-follicular-lymphoma-car-t-cell-therapy/ 2026-05-26T19:44:31+00:00 https://researchtopractice.com/activity/striving-for-consensus-optimizing-the-selection-and-sequencing-of-therapy-for-patients-with-relapsed-refractory-follicular-lymphoma-other-novel-therapies/ 2026-05-26T19:45:21+00:00 https://researchtopractice.com/activity/the-optimal-implementation-of-antibody-drug-conjugates-in-the-care-of-patients-with-cancer/ 2026-05-26T19:56:52+00:00 https://researchtopractice.com/activity/addressing-current-questions-and-controversies-in-the-care-of-patients-with-ovarian-cancer/ 2026-05-26T20:00:42+00:00 https://researchtopractice.com/activity/addressing-current-questions-related-to-novel-treatment-approaches-for-urothelial-bladder-cancer-and-prostate-cancer/ 2026-05-26T20:07:08+00:00 https://researchtopractice.com/activity/addressing-current-questions-related-to-the-management-of-renal-cell-carcinoma/ 2026-05-26T20:08:21+00:00 https://researchtopractice.com/activity/biomarker-assessment-and-related-treatment-decision-making-for-patients-with-colorectal-cancer/ 2026-05-26T20:09:18+00:00 https://researchtopractice.com/activity/current-and-future-integration-of-antibody-drug-conjugates-into-the-management-of-metastatic-breast-cancer/ 2026-05-26T20:47:43+00:00 https://researchtopractice.com/activity/investigators-discuss-available-research-guiding-the-management-of-relapsed-refractory-multiple-myeloma-what-happened-at-ash-2025/ 2026-05-27T16:41:51+00:00 https://researchtopractice.com/activity/consensus-or-controversy-clinical-investigators-provide-perspectives-on-the-current-and-future-care-of-patients-with-follicular-lymphoma-symposium-video-proceedings/ 2026-05-27T17:03:22+00:00 https://researchtopractice.com/activity/consensus-or-controversy-clinical-investigators-provide-perspectives-on-the-current-and-future-care-of-patients-with-relapsed-refractory-multiple-myeloma/ 2026-05-27T17:07:26+00:00 http://researchtopractice.com/wp-content/uploads/2025/10/ja2.png http://researchtopractice.com/wp-content/uploads/2025/10/cme.png https://researchtopractice.com/activity/diabetology-for-the-medical-oncologist-managing-hyperglycemia-in-patients-with-breast-cancer-receiving-agents-targeting-the-pi3k-akt-pten-pathway/ 2026-05-27T18:08:18+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-management-of-myelofibrosis-and-systemic-mastocytosis/ 2026-05-27T18:23:09+00:00 https://researchtopractice.com/activity/optimizing-the-use-of-immunotherapy-mrd-assessment-and-other-novel-approaches-for-patients-with-localized-colorectal-cancer-3/ 2026-05-27T18:32:23+00:00 https://researchtopractice.com/activity/optimizing-the-use-of-oral-selective-estrogen-receptor-degraders-for-hr-positive-metastatic-breast-cancer-part-2/ 2026-05-27T18:39:30+00:00 https://researchtopractice.com/activity/esmo-congress-2025-review-urothelial-bladder-cancer-2/ 2026-05-27T18:55:28+00:00 https://researchtopractice.com/activity/managing-ocular-toxicities-associated-with-antibody-drug-conjugates-and-other-cancer-therapies-part-1/ 2026-05-27T19:02:47+00:00 https://researchtopractice.com/activity/inside-the-issue-managing-ocular-toxicities-associated-with-antibody-drug-conjugates-and-other-cancer-therapies-part-2/ 2026-05-27T19:04:24+00:00 https://researchtopractice.com/activity/practical-perspectives-clinical-investigators-review-actual-cases-of-patients-with-her2-positive-gastrointestinal-cancers/ 2026-05-27T19:31:16+00:00 https://researchtopractice.com/activity/practical-perspectives-the-current-role-of-bispecific-antibodies-in-the-management-of-lymphoma-what-happened-at-ash-2025/ 2026-05-27T19:56:17+00:00 https://researchtopractice.com/activity/striving-for-consensus-optimizing-the-use-of-molecular-residual-disease-analysis-to-inform-colorectal-cancer-management/ 2026-05-27T20:45:36+00:00 https://researchtopractice.com/activity/what-clinicians-want-to-know-first-line-and-maintenance-therapy-for-patients-with-er-positive-her2-positive-metastatic-breast-cancer/ 2026-05-27T21:16:26+00:00 https://researchtopractice.com/activity/firstlinetherapysclc2025-1/ 2026-05-27T21:18:49+00:00 https://researchtopractice.com/activity/optimizing-the-selection-of-first-line-therapy-for-patients-with-multiple-myeloma-2/ 2026-05-27T21:28:54+00:00 https://researchtopractice.com/activity/investigators-discuss-the-role-of-novel-treatment-approaches-in-the-care-of-patients-with-follicular-lymphoma-and-diffuse-large-b-cell-lymphoma/ 2026-05-27T21:41:15+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-colorectal-cancer-5/ 2026-05-27T21:50:45+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-colorectal-cancer-4/ 2026-05-27T21:50:59+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-colorectal-cancer-6/ 2026-05-27T21:51:57+00:00 https://researchtopractice.com/activity/selection-and-sequencing-of-therapy-for-metastatic-triple-negative-breast-cancer/ 2026-05-27T22:44:16+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-prostate-cancer/ 2026-05-27T22:53:27+00:00 https://researchtopractice.com/activity/current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays-in-the-treatment-of-cancer-2/ 2026-05-27T23:33:53+00:00 https://researchtopractice.com/activity/current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays-in-the-treatment-of-cancer/ 2026-05-27T23:40:09+00:00 https://researchtopractice.com/activity/5700-aon25-cll/ 2026-05-28T00:01:49+00:00 https://researchtopractice.com/activity/5700-aon25-ovarian/ 2026-05-28T00:02:15+00:00 https://researchtopractice.com/activity/5700-aon25-ge/ 2026-05-28T00:02:37+00:00 https://researchtopractice.com/activity/5700-aon25-lung/ 2026-05-28T18:04:13+00:00 https://researchtopractice.com/activity/patientproject2025-cartclinicians/ 2026-05-28T20:41:35+00:00 https://researchtopractice.com/activity/investigators-discuss-the-optimal-management-of-her2-positive-breast-cancer/ 2026-05-28T20:49:49+00:00 https://researchtopractice.com/activity/clinical-investigators-provide-perspectives-on-the-current-and-future-management-of-acute-myeloid-leukemia/ 2026-05-28T21:05:51+00:00 https://researchtopractice.com/activity/current-and-future-roles-of-immunotherapy-and-targeted-therapy-in-the-management-of-advanced-gastroesophageal-cancers/ 2026-05-28T21:13:56+00:00 https://researchtopractice.com/activity/oncology-today-with-dr-neil-love-optimal-management-of-squamous-cell-carcinoma-of-the-anal-canal/ 2026-05-28T21:27:36+00:00 https://researchtopractice.com/activity/rapid-case-review-investigators-provide-perspectives-on-actual-cases-of-metastatic-bladder/ 2026-05-28T21:59:15+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-hormone-receptor-positive-breast-cancer/ 2026-06-01T14:37:01+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-chronic-lymphocytic-leukemia/ 2026-06-01T14:43:43+00:00 https://researchtopractice.com/activity/the-role-of-dll3-targeting-bispecific-t-cell-engagers-for-small-cell-lung-cancer/ 2026-06-01T14:44:42+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-chronic-myeloid-leukemia/ 2026-06-01T14:45:44+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-pancreatic-cancer/ 2026-06-01T14:46:29+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-endometrial-cancer/ 2026-06-01T14:47:21+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-gastroesophageal-cancers/ 2026-06-01T15:12:06+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-prostate-cancer-2/ 2026-06-01T15:15:52+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-prostate-cancer/ 2026-06-01T15:16:22+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-prostate-cancer-6/ 2026-06-01T15:17:15+00:00 https://researchtopractice.com/activity/reviewing-the-role-of-oral-serds-in-the-management-of-er-positive-metastatic-breast-cancer-issue-7/ 2026-06-01T15:24:18+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-chronic-lymphocytic-leukemia-edition-2/ 2026-06-01T15:26:00+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-chronic-lymphocytic-leukemia-edition/ 2026-06-01T15:31:13+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-non-hodgkin-lymphoma-2/ 2026-06-01T15:32:22+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-non-hodgkin-lymphoma/ 2026-06-01T15:32:55+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-non-hodgkin-lymphoma-3/ 2026-06-01T15:33:32+00:00 https://researchtopractice.com/activity/practical-perspectives-on-the-current-and-future-management-of-immune-thrombocytopenia-what-happened-at-ash-2025/ 2026-06-01T16:45:01+00:00 https://researchtopractice.com/activity/clinical-investigators-discuss-the-emerging-role-of-akt-inhibitors-in-the-care-of-patients-with-prostate-cancer/ 2026-06-01T17:37:57+00:00 https://researchtopractice.com/activity/reviewing-the-role-of-oral-serds-in-the-management-of-er-positive-metastatic-breast-cancer-issue-8/ 2026-06-01T17:38:48+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-multiple-myeloma-edition/ 2026-06-01T17:39:42+00:00 https://researchtopractice.com/activity/key-presentations-from-the-66th-american-society-of-hematology-ash-annual-meeting-multiple-myeloma-edition-2/ 2026-06-01T17:40:13+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-myelofibrosis-2/ 2026-06-01T17:42:08+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-myelofibrosis/ 2026-06-01T17:43:15+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-myelofibrosis-3/ 2026-06-01T17:44:01+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-the-management-of-breast-cancer/ 2026-06-01T17:44:54+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-non-hodgkin-lymphoma/ 2026-06-01T17:45:58+00:00 https://researchtopractice.com/activity/optimizing-biomarker-assessment-and-related-treatment-decision-making-for-patients-with-hr-positive-metastatic-breast-cancer-2/ 2026-06-02T01:03:40+00:00 https://researchtopractice.com/activity/optimizing-biomarker-assessment-and-related-treatment-decision-making-for-patients-with-hr-positive-metastatic-breast-cancer/ 2026-06-02T01:04:06+00:00 https://researchtopractice.com/activity/the-potential-role-of-trop2-and-cdh6-directed-antibody-drug-conjugates-in-gynecologic-cancers/ 2026-06-02T18:33:01+00:00 https://researchtopractice.com/activity/understanding-the-current-paradigm-and-new-approaches-in-the-care-of-patients-with-prostate-cancer-2/ 2026-06-04T19:48:53+00:00 https://researchtopractice.com/activity/current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays-in-the-treatment-of-genitourinary-cancers-issue-1/ 2026-06-05T03:28:42+00:00 https://researchtopractice.com/activity/current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays-in-the-treatment-of-genitourinary-cancers-issue-2/ 2026-06-05T20:12:36+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-small-cell-lung-cancer-3/ 2026-06-05T22:00:52+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-small-cell-lung-cancer/ 2026-06-05T22:07:20+00:00 https://researchtopractice.com/activity/clinical-investigator-perspectives-on-the-most-relevant-new-datasets-and-advances-in-small-cell-lung-cancer-2/ 2026-06-05T23:49:53+00:00 https://researchtopractice.com/activity/management-of-desmoid-tumors-2/ 2026-06-09T13:23:39+00:00 https://researchtopractice.com/activity/activity-management-of-desmoid-tumors-3/ 2026-06-09T13:24:13+00:00 https://researchtopractice.com/activity/management-of-desmoid-tumors/ 2026-06-09T13:26:43+00:00